CCR5 antagonist reduces HIV-induced amyloidogenesis, tau pathology, neurodegeneration, and blood-brain barrier alterations in HIV-infected hu-PBL-NSG mice
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1750-1326
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
CCR5 antagonist reduces HIV-induced amyloidogenesis, tau pathology, neurodegeneration, and blood-brain barrier alterations in HIV-infected hu-PBL-NSG mice ; volume:16 ; number:1 ; day:22 ; month:11 ; year:2021 ; pages:1-23 ; date:12.2021
Molecular neurodegeneration ; 16, Heft 1 (22.11.2021), 1-23, 12.2021
- Creator
-
Bhargavan, Biju
Woollard, Shawna M.
McMillan, Jo Ellyn
Kanmogne, Georgette D.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13024-021-00500-0
- URN
-
urn:nbn:de:101:1-2022013006001192014191
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:34 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bhargavan, Biju
- Woollard, Shawna M.
- McMillan, Jo Ellyn
- Kanmogne, Georgette D.
- SpringerLink (Online service)
Other Objects (12)
Reduced CCR5 expression among Uganda HIV controllers
The HIV co-receptor CCR5 regulates osteoclast function
Mitochondrial impairment in HIV-infected children
Hypogonadism in the HIV-Infected Man
A possible role for CCR5 in the progression of atherosclerosis in HIV-infected patients: a cross-sectional study
Bedeutung des CCR5-Chemokinrezeptors in der HIV-, HGV-Koinfektion
Clinical use of CCR5 inhibitors in HIV and beyond
Natural anti-CCR5 antibodies in HIV-infection and -exposure
Update on Aplaviroc: An HIV Entry Inhibitor Targeting CCR5
Influence of smoking on HIV infection among HIV-infected Japanese men
CCR5 D32 modifies 15-year mortality risk associated with well-established clinical and immunological factors among HIV-infected patients
Screening colonoscopy in HIV-infected patients: high rates of mucosal abnormalities in a German HIV-infected cohort
Reduced CCR5 expression among Uganda HIV controllers
The HIV co-receptor CCR5 regulates osteoclast function
Mitochondrial impairment in HIV-infected children
Hypogonadism in the HIV-Infected Man
A possible role for CCR5 in the progression of atherosclerosis in HIV-infected patients: a cross-sectional study
Bedeutung des CCR5-Chemokinrezeptors in der HIV-, HGV-Koinfektion
Clinical use of CCR5 inhibitors in HIV and beyond
Natural anti-CCR5 antibodies in HIV-infection and -exposure
Update on Aplaviroc: An HIV Entry Inhibitor Targeting CCR5
Influence of smoking on HIV infection among HIV-infected Japanese men
CCR5 D32 modifies 15-year mortality risk associated with well-established clinical and immunological factors among HIV-infected patients
Screening colonoscopy in HIV-infected patients: high rates of mucosal abnormalities in a German HIV-infected cohort
Reduced CCR5 expression among Uganda HIV controllers
The HIV co-receptor CCR5 regulates osteoclast function
Mitochondrial impairment in HIV-infected children
Hypogonadism in the HIV-Infected Man
A possible role for CCR5 in the progression of atherosclerosis in HIV-infected patients: a cross-sectional study
Bedeutung des CCR5-Chemokinrezeptors in der HIV-, HGV-Koinfektion
Clinical use of CCR5 inhibitors in HIV and beyond
Natural anti-CCR5 antibodies in HIV-infection and -exposure
Update on Aplaviroc: An HIV Entry Inhibitor Targeting CCR5
Influence of smoking on HIV infection among HIV-infected Japanese men
CCR5 D32 modifies 15-year mortality risk associated with well-established clinical and immunological factors among HIV-infected patients